Increases in tick-borne disease prevalence and transmission are important public health
issues. Efforts to control these emerging diseases are frustrated by the struggle to control tick …

Lyme borreliosis is a tick-borne disease that predominantly occurs in temperate regions of
the northern hemisphere and is primarily caused by the bacterium Borrelia burgdorferi in …

Lyme disease (also known as Lyme borreliosis) is the most common vector-borne disease in
the United States with an estimated 476,000 cases per year. While historically, the long-term …

Abstract In the United States, Lyme disease is caused by Borrelia burgdorferi and
transmitted to humans by blacklegged ticks. Patients with an erythema migrans lesion and …

With almost 700 000 estimated cases each year in the United States and Europe, Lyme
borreliosis (LB), also called Lyme disease, is the most common tick-borne illness in the …

Within the past 30 yr molecular assays have largely supplanted classical methods for
detection of tick-borne agents. Enhancements provided by molecular assays, including …

Lyme borreliosis is caused by a growing list of related, yet distinct, spirochetes with complex
biology and sophisticated immune evasion mechanisms. It may result in a range of clinical …

In omics experiments, variable selection involves a large number of metabolites/genes and
a small number of samples (the n< p problem). The ultimate goal is often the identification of …

Lyme disease is a tick-borne illness caused by the bacterium Borrelia burgdorferi, and
approximately 10 to 20% of patients report persistent symptoms lasting months to years …

Lyme disease prevails as the most commonly transmitted tick-borne infection in the United
States, and serologic evaluation for antibodies to Borrelia burgdorferi remains the …